188 related articles for article (PubMed ID: 33094472)
1. Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy.
Suomalainen O; Pilv J; Loimaala A; Mätzke S; Heliö T; Uusitalo V
J Nucl Cardiol; 2022 Jun; 29(3):1021-1029. PubMed ID: 33094472
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of
Uusitalo V; Suomalainen O; Loimaala A; Mätzke S; Heliö T
Heart Lung Circ; 2022 May; 31(5):629-637. PubMed ID: 35063379
[TBL] [Abstract][Full Text] [Related]
3. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
[TBL] [Abstract][Full Text] [Related]
4. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
5. Cardiac morbidity and the cause of death in elderly patients with prostate cancer and incidental cardiac uptake on bone scintigraphy.
Juntunen E; Suomalainen O; Mätzke S; Heliö T; Loimaala A; Uusitalo V
Clin Physiol Funct Imaging; 2024 Jan; 44(1):49-55. PubMed ID: 37421321
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
[TBL] [Abstract][Full Text] [Related]
7. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
8. SPECT/CT SUV-based metrics: A promising diagnostic tool in classifying patients with suspected transthyretin cardiac amyloidosis among the different Perugini grades?
Koukouraki S; Kapsoritakis N; Bourogianni O; Stathaki M; Zaganas I; Patrianakos A; Plevritaki A; Korela D; Marketou M; Foukarakis E
Hell J Nucl Med; 2023; 26(3):172-180. PubMed ID: 38085832
[TBL] [Abstract][Full Text] [Related]
9. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
[TBL] [Abstract][Full Text] [Related]
10. Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.
Avalon JC; Fuqua J; Deskins S; Miller T; Conte J; Martin D; Marano G; Yanamala N; Mills J; Bianco C; Patel B; Seetharam K; Raylman R; Sengupta PP; Hamirani YS
J Nucl Cardiol; 2023 Feb; 30(1):127-139. PubMed ID: 35655113
[TBL] [Abstract][Full Text] [Related]
11. Convolutional neural networks for detection of transthyretin amyloidosis in 2D scintigraphy images.
Halme HL; Ihalainen T; Suomalainen O; Loimaala A; Mätzke S; Uusitalo V; Sipilä O; Hippeläinen E
EJNMMI Res; 2022 May; 12(1):27. PubMed ID: 35524861
[TBL] [Abstract][Full Text] [Related]
12.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
13. The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy.
Itzhaki Ben Zadok O; Ruhrman-Sahar N; Mats I; Vaxman I; Shiyovich A; Aviv Y; Vaturi M; Wiessman M; Shochat T; Kandinov I; Kornowski R; Hamdan A
ESC Heart Fail; 2023 Jun; 10(3):1666-1676. PubMed ID: 36799266
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
[TBL] [Abstract][Full Text] [Related]
15. Incidental cardiac uptake of
Salvalaggio A; Cipriani A; Righetto S; Artioli P; Sinigiani G; De Michieli L; Cason M; Pilichou K; Cecchin D; Briani C
J Nucl Cardiol; 2022 Dec; 29(6):3419-3425. PubMed ID: 35437680
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy.
Porcari A; Fontana M; Canepa M; Biagini E; Cappelli F; Gagliardi C; Longhi S; Pagura L; Tini G; Dore F; Bonfiglioli R; Bauckneht M; Miceli A; Girardi F; Martini AL; Barbati G; Costanzo EN; Caponetti AG; Paccagnella A; Sguazzotti M; La Malfa G; Zampieri M; Sciagrà R; Perfetto F; Rowczenio D; Gilbertson J; Hutt DF; Hawkins PN; Rapezzi C; Merlo M; Sinagra G; Gillmore JD
Circulation; 2024 Apr; 149(15):1157-1168. PubMed ID: 38328945
[TBL] [Abstract][Full Text] [Related]
17. Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes.
Vranian MN; Sperry BW; Hanna M; Hachamovitch R; Ikram A; Brunken RC; Jaber WA
J Nucl Cardiol; 2018 Aug; 25(4):1247-1256. PubMed ID: 28050864
[TBL] [Abstract][Full Text] [Related]
18. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA
J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490
[TBL] [Abstract][Full Text] [Related]
19. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis.
Sperry BW; Gonzalez MH; Brunken R; Cerqueira MD; Hanna M; Jaber WA
J Nucl Cardiol; 2019 Oct; 26(5):1630-1637. PubMed ID: 29344917
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Quantitative
Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
Heart Lung Circ; 2022 Jun; 31(6):804-814. PubMed ID: 35181228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
